Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 26 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Risk for diabetes can be detected prior to liver transplants

New-onset diabetes mellitus after liver transplantation is related to risk factors that can be detected prior to the graft, reports January's Liver Transplantation.

News image

fiogf49gjkf04

New-onset diabetes mellitus remains a common complication of liver transplantation.

Dr Faouzi Saliba and colleagues from France studied incidence and risk factors in 211 patients who had undergone a primary liver transplantation between 6 and 24 months previously.

The research team conducted a cross-sectional and retrospective multicenter study.

The researchers collected on consecutive patients at a single routine post-liver transplantation consultation.

The overall incidence of new-onset diabetes mellitus was 23%
Liver Transplantation

Demographic details, immunosuppressive regimens, familial and personal histories, hepatitis status, and cardiovascular risk were analyzed.

The team assessed those with newly developed diabetes, according to American Diabetes Association/World Health Organization criteria.

The researchers found that the overall incidence of new-onset diabetes mellitus was 23%.

The incidence in tacrolimus-treated patients was 24%, and 17% in cyclosporine-treated patients.

A total of 81% of the cases were diagnosed within 3 months of liver transplantation.

Among Hepatitis C virus-infected patients, new-onset diabetes mellitus incidence was 42%.

However, the team observed that among those patients negative for Hepatitis C virus, the incidence was only 19%.

With tacrolimus, the incidence of new-onset diabetes mellitus in the Hepatitis C virus positive patients was higher than in the Hepatitis C virus negative patients.

Only 17% of the Hepatitis C virus positive patients developed new-onset diabetes mellitus on cyclosporine.

The researchers found that impaired fasting glucose ther independent pretransplantation risk factors for new-onset diabetes mellitus.

A maximum lifetime body-mass index over 25 kg/m2 was an independent pretransplantation risk factor for new-onset diabetes mellitus.

Dr Saliba's team concludes, “Emergence of new-onset diabetes mellitus after liver transplantation is related to risk factors that can be detected prior to the graft.”

“These risk factors include maximum lifetime body-mass index, impaired fasting glucose, and Hepatitis C virus status.”

“Tacrolimus induced a higher incidence of new-onset diabetes mellitus in the Hepatitis C virus positive compared to the Hepatitis C virus negative patients.”

“The treatment should be tailored to the patient's risk especially in case of Hepatitis C virus infection.”

Liver Transplant 2007: 13(1): 136-44
11 January 2007

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us